Volume 7 Cancer Chemotherapy I

  • K. Hellmann
  • T. A. Connors

Table of contents

  1. Front Matter
    Pages i-xii
  2. Emil Frei III
    Pages 1-17
  3. Norbert Brock
    Pages 19-50
  4. Jennifer A. C. Sykes
    Pages 83-88
  5. Nicholas R. Bachur
    Pages 105-111
  6. Wolfgang Sadée
    Pages 113-117
  7. John M. Venditti, Mary K. Wolpert-DeFilippes
    Pages 129-147
  8. M.J. Cleare
    Pages 149-157
  9. Phillip S. Schein, Tom Anderson, Mary G. McMenamin, Joan Bull
    Pages 159-166
  10. K. Hellmann
    Pages 183-186
  11. G. E. Adams, J. Denekamp, J. E. Fowler
    Pages 187-206
  12. J. Rygard, Hanne S. Hansen
    Pages 207-210

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • K. Hellmann
    • 1
  • T. A. Connors
    • 2
  1. 1.Westminster Hospital and Imperial Cancer Research FundUK
  2. 2.Chester Beatty Research InstituteUK

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1976
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-4351-6
  • Online ISBN 978-1-4613-4349-3
  • About this book